CN108379199A - 一种植物面膜粉 - Google Patents
一种植物面膜粉 Download PDFInfo
- Publication number
- CN108379199A CN108379199A CN201810505363.9A CN201810505363A CN108379199A CN 108379199 A CN108379199 A CN 108379199A CN 201810505363 A CN201810505363 A CN 201810505363A CN 108379199 A CN108379199 A CN 108379199A
- Authority
- CN
- China
- Prior art keywords
- parts
- plant
- radix
- powder
- ginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 46
- 241000196324 Embryophyta Species 0.000 claims abstract description 48
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 30
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 30
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 20
- 235000008434 ginseng Nutrition 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 16
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims abstract description 13
- 241001656831 Arctous alpina Species 0.000 claims abstract description 12
- 241000605372 Fritillaria Species 0.000 claims abstract description 12
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 12
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 12
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 11
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 11
- 241000133134 Saussurea Species 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 238000007873 sieving Methods 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- 241001145025 Saussurea involucrata Species 0.000 claims description 3
- 238000012376 hot air sterilization Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 27
- 239000000126 substance Substances 0.000 abstract description 8
- 239000000203 mixture Substances 0.000 abstract description 5
- 230000000857 drug effect Effects 0.000 abstract description 4
- 239000003755 preservative agent Substances 0.000 abstract description 4
- 230000002335 preservative effect Effects 0.000 abstract description 4
- 239000005556 hormone Substances 0.000 abstract description 3
- 229940088597 hormone Drugs 0.000 abstract description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 abstract description 3
- 229910052753 mercury Inorganic materials 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 231100000765 toxin Toxicity 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- 239000003814 drug Substances 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 5
- -1 tanshinone Chemical class 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000935235 Fritillaria meleagris Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241001480037 Microsporum Species 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 240000001341 Reynoutria japonica Species 0.000 description 2
- 235000018167 Reynoutria japonica Nutrition 0.000 description 2
- 240000007164 Salvia officinalis Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- FIGVVZUWCLSUEI-UHFFFAOYSA-N tricosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCC FIGVVZUWCLSUEI-UHFFFAOYSA-N 0.000 description 2
- HSTZMXCBWJGKHG-UHFFFAOYSA-N (E)-piceid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(C=CC=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- SMRPGWBDLOQHOS-UHFFFAOYSA-N 5-[4,5-dihydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-3,4-dihydroxy-6-[[9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]oxane-2-carboxylic acid Chemical compound OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(C(O)C2O)C(O)=O)OC2C(C3C(C4C(C5(CCC6(C)C(O)CC(C)(C)CC6C5=CC4=O)C)(C)CC3)(C)CC2)(C)CO)OC(CO)C(O)C1O SMRPGWBDLOQHOS-UHFFFAOYSA-N 0.000 description 1
- VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241001313855 Bletilla Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- MPJKWIXIYCLVCU-UHFFFAOYSA-N Folinic acid Natural products NC1=NC2=C(N(C=O)C(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)CC(=O)O)CN2)C(=O)N1 MPJKWIXIYCLVCU-UHFFFAOYSA-N 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241001547125 Fritillaria thunbergii Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- HSTZMXCBWJGKHG-CENDIDJXSA-N Piceid Natural products OC[C@@H]1O[C@@H](Oc2cc(O)cc(C=Cc3ccc(O)cc3)c2)[C@H](O)[C@H](O)[C@H]1O HSTZMXCBWJGKHG-CENDIDJXSA-N 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 244000292697 Polygonum aviculare Species 0.000 description 1
- 235000006386 Polygonum aviculare Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 1
- 235000008191 folinic acid Nutrition 0.000 description 1
- 239000011672 folinic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- NZYSZZDSYIBYLC-UHFFFAOYSA-N glycycoumarin Chemical compound C=1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OC(=O)C=1C1=CC=C(O)C=C1O NZYSZZDSYIBYLC-UHFFFAOYSA-N 0.000 description 1
- NPQWZAAWZLVQIZ-UHFFFAOYSA-N glycycoumarin Natural products COc1cc2OC(=O)C(=Cc2c(O)c1CC=C(C)C)c3ccc(O)cc3O NPQWZAAWZLVQIZ-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 229960001691 leucovorin Drugs 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003643 myeloid progenitor cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- HSTZMXCBWJGKHG-OUUBHVDSSA-N piceide Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(C=CC=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-OUUBHVDSSA-N 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- PPRSVUXPYPBULA-UHFFFAOYSA-N saponin A Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(CO)C(O)C(O)C6=O)C(C)(C)C5CCC34C)C2C1)C(=O)O PPRSVUXPYPBULA-UHFFFAOYSA-N 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- HSTZMXCBWJGKHG-CUYWLFDKSA-N trans-piceid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-CUYWLFDKSA-N 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种植物面膜粉，该植物面膜粉包括以下重量份数的植物原料：雪莲花4～10份，贝母6～12份，西洋参5～12份，三七4～8份，冬虫夏草2～6份，人参3～8份，沙棘2～6份，当归9～13份，丹参2～6份，熊果4～8份，甘草3～5份。采用雪莲花，贝母，西洋参，三七，冬虫夏草，人参，沙棘，当归，丹参，熊果，甘草进行合理复配，这十二植物原料能产生相畏作用，且无药效相冲的副作用，能从根本性提升肌肤自身的排毒与滋养功能，还原肌肤应有的活力，滋养效果好，能够改善肤质，不会产生依赖性，不含任何激素、化学防腐剂、铅汞等对肌肤有害的化学成分。
Description
技术领域
本发明属于化妆品技术领域，具体涉及一种植物面膜粉。
背景技术
目前，美容护肤产品品目繁多，功效良莠不齐。而其中比较优秀的产品以外国品牌居多，但是这些品牌基本以化学成分为核心，在给肌肤带来一定功效的同时，也容易引发依赖性以及副作用等问题，例如，过敏、护肤效果阶梯递减、色素沉着等。
近几年，随着中医药文化再度兴起，市场上也开始有中药配方的面膜出现，但这些中药面膜存在一些不足和缺陷。例如，市场现存的中药面膜强调抑制，比如抑制黑色素，抑制痤疮等，而忽略皮肤最重要的是疏通与滋养，不仅滋养效果不佳，难以改善肤质，还容易导致依赖性的产生，一旦停止使用，效果则很难延续甚至迅速恶化；市场现存的中药面膜多采用熬制之后添加其他成分制成膏状形态，同时为了保持其有效期不发生质变，而加入了化学防腐剂等其他添加剂，这些添加剂的成分就如同前文所述的以化学成分为核心的化妆品一样，存在诸多的隐形副作用。
发明内容
本发明的目的在于提供一种植物面膜粉，该面膜粉能改善肤质、无依赖性且不含任何激素、化学防腐剂、铅汞等对肌肤有害的化学成分；同时本发明还提供一种上述一种植物面膜粉的制备方法。
为实现上述目的，本发明一种植物面膜粉所采用的技术方案是：所述植物面膜粉包括以下重量份数的植物原料：雪莲花4～10份，贝母6～12份，西洋参5～12份，三七4～8份，冬虫夏草2～6份，人参3～8份，沙棘2～6份，当归9～13份，丹参2～6份，熊果4～8份，甘草3～5份。
优选的，所述植物面膜粉主要由以下重量份数的中药原材料制成，雪莲花6份，贝母8份，西洋参7份，三七5份，冬虫夏草4份，人参6份，沙棘4份，当归10份，丹参4份，熊果5份，甘草4份。
本发明的一种植物面膜粉，各中植物原料的功效及作用如下：
雪莲花：莲花性温，味甘苦，入肝、脾、肾三经，具除寒、壮阳、调经、止血之功，用于治疗阳痿、腰膝软弱、妇女月经不调、崩漏带下、风湿性关节炎及外伤出血等症。《本草纲目拾遗》载：雪莲“性大热，能补精益阳”；《新疆中草药》载：“雪莲性温、微苦，功能祛风除湿”。何首乌：为蓼科蓼属植物何首乌的块根；含有蒽醌类化合物如大黄素、大黄酚、大 黄酚蒽酮、何首乌丙素、云杉新苷等多种活性成分；性味苦、甘，涩，微温，归肝、心、肾经；能 养血滋阴、润肠通便、祛风、解毒；主治头昏目眩、心悸、失眠、腰膝酸软、须发早白、耳鸣、肠 燥便秘、久疟体虚、风疹瘙痒、疮痈、瘰疬等；现代药理学证明何首乌具有降血脂、抗动脉粥 样硬化、增强免疫、延缓衰老、抗遗传损伤、抗炎、镇痛等作用。
贝母：是多年生草本植物，为常见中药材。贝母按产地和品种的不同，可分为川贝母、浙贝母和土贝母、伊贝母四大类。贝母有清热散结、止咳化痰的功效与作用。
西洋参：甘、微苦，寒，归肺、胃、心、肾经，含人参皂苷类17 种，其结构与人参相同，但是其性是补而不燥，在本发明中具有抗疲劳、增强免疫力、降血脂、降血糖、保护肝脏、延长衰老抗氧化、减肥等作用，在配方中起主导作用。
三七：为五加科植物三七Panax notoginseng 的干燥根。秋季花开前采挖，洗净，分开主根、支根及茎基，干燥。支根习称“筋条”，茎基习称“剪口”。性甘、微苦，温。归肝、胃经。功效：散瘀止血，消肿定痛。用于吐血，衄血，便血，崩漏，外伤出血，胸腹剌痛，跌扑肿痛。
冬虫夏草：甘，温。归肺、肾经。虫草具有抗菌抗病毒功效，虫草煎剂对须疮癣菌、絮状表皮癣菌、石膏样小芽胞癣菌、羊毛状小芽胞癣菌等真菌均有抑制作用。
人参：人参：甘、微苦，平，归脾、肺、心经，大补元气，复脉固脱，补脾益肺，生津，安神，用于体虚欲脱，肢冷脉微，脾虚食少，肺虚喘咳，津伤口渴，内热消渴，久病虚羸，惊悸失眠，阳痿宫冷，心力衰竭，心原性休克。现代医学普遍认为人参对中枢神经系统、心血管系统、消化系统、内分泌系统、泌尿生殖系统有广泛作用，可提高人体免疫力，增强机体对有害刺激的抵抗力。人参在美容美发、化妆品领域已被广泛应用，人参中含有多种人参皂苷、氨基酸、维生素及矿物质，具有促进皮下毛细血管的血液循环、加强皮肤营养、调节皮肤水分平衡等作用，人参能减缓皮肤衰老，防止皮肤干燥脱水，增强皮肤弹性，从而起到保持皮肤光泽、鲜嫩，防止和减少皮肤皱纹作用。人参中的活性物质还具有抑制黑色素沉积作用，使皮肤洁白光滑。因此，人参不仅可以强身健体，还具有抗衰老、护肤美容作用。
沙棘：沙棘果实入药具有止咳化痰、健胃消食、活血散瘀之功效。现代医学研究，沙棘可降低胆固醇，缓解心绞痛发作，还有防治冠状动脉粥样硬化性心脏病的作用。
当归：味甘，性温，归肝、心、脾经。主要功效为补血活血、调经止痛、润燥滑肠。主治血虚诸证、月经不调等症。当归是中医补血活血要药。当归水浸液给小鼠口服能显著促进血红蛋白及红细胞的生成。其抗贫血作用可能与所含的维生素B12、烟酸、亚叶酸及生物素、叶酸等成分有关。当归多糖能增加外周血红细胞、白细胞、血红蛋白及骨髓有核细胞数，这种作用特别是在外周血细胞减少和骨髓受到抑制时尤为明显。当归补血作用机理之一可能与当归多糖刺激多能造血干细胞(CFU-S)、造血祖细胞增殖、分化有关。
丹参：为唇形科鼠尾草属植物丹参的根；含有醌类化合物如丹参酮、丹参酮基内酯，水溶性酚酸类化合物如丹参酚酸、原儿茶酸，脂肪酸类如亚麻酸、亚油酸，还含有黄芩苷、胡萝卜苷等多种活性成分；性味苦，微寒，归心、心包、肝经；能活血化瘀，调经止痛，除烦安神，凉血消痈；主治妇女月经不调、痛经、经闭、产后瘀滞腹痛、心腹疼痛、癥瘕积聚、热痹肿痛、跌打损伤、热人营血、烦躁不安、心烦失眠、痈疮肿毒等；现代药理学证明丹参对心脑血管系统、呼吸系统、血脂和动脉粥样硬化、肝脏、肿瘤和免疫功能等产生影响，还具有抗炎、抗过敏、抗胃溃疡等作用。
熊果：做为药用植物，它的叶子中含有熊果素，熊果素有抗菌、美白的功效。
甘草：为豆科甘草属植物甘草、光皮甘草、胀果甘草的根及根茎；含有三萜皂苷如甘草甜素、乌拉尔甘草皂苷A、B等，黄酮类化合物如甘草苷元、甘草苷等，香豆素类化合物如甘草香豆素、甘草酚等，生物碱类如喹啉类、异喹啉类等，多糖如甘草葡聚糖GBW、甘草多糖UA、UB、UC等，还含有甘草苯丙呋喃、正二十三烷等多种有效成分；甘草性味甘、平，归脾、胃、心、肺经；能和中缓急、润肺、解毒、调和诸药；炙用治脾胃虚弱、倦怠食少、腹痛便溏、四肢挛急疼痛、心悸、脏躁、肺痿咳嗽，生用治咽喉肿痛、痈疮肿毒、小儿胎毒及药物、食物中毒等；现代药理学证明甘草具有抗微生物、抗炎、镇咳、祛痰、抗肿瘤、抗炎、镇咳、祛痰、抗肿瘤、抗突变、抗氧化等功效，对消 化系统、心血管系统、生殖系统及脑、肾功能等具有调节作用。
上述一种植物面膜粉的制备方法，包括以下步骤：
（1）将上述植物原料清洗干净，烘干后按照重量份数混合在一起；
（2）将步骤（1）的混合植物原料研磨成粉末，并将粉末过100～200目筛，收集过筛后的粉末；
（3）将步骤（2）中过筛后的粉末灭菌处理，即得所述的植物粉。
进一步的，所述步骤（1）中采用的烘干温度为50～55℃。
进一步的，所述步骤（2）中筛网目数为150～180。
进一步的，所述步骤（3）中灭菌处理采用真空紫外灭菌或干热灭菌。
本发明的有益效果：本发明采用雪莲花，贝母，西洋参，三七，冬虫夏草，人参，沙棘，当归，丹参，熊果，甘草进行合理复配，这十二种植物材料能产生相畏作用，且无药效相冲的副作用，能从根本性提升肌肤自身的排毒与滋养功能，还原肌肤应有的活力，滋养效果好，能够改善肤质，不会产生依赖性，不含任何激素、化学防腐剂、铅汞等对肌肤有害的化学成分。
具体实施方式
下面结合实施例对本发明作进一步的说明。
实施例1
本实施例的植物面膜粉，包括以下重量份数的植物原料：雪莲花6份，贝母8份，西洋参7份，三七5份，冬虫夏草4份，人参6份，沙棘4份，当归10份，丹参4份，熊果5份，甘草4份。
本实施例的植物面膜粉的制备方法，包括以下步骤：
（1）将上述植物原料清洗干净，50度烘干后按照重量份数混合在一起；
（2）将步骤（1）的混合植物原料研磨成粉末，并将粉末过150目筛，收集过筛后的粉末；
（3）将步骤（2）中过筛后的粉末采用真空紫外灭菌处理，即得所述的植物面膜粉。
实施例2
本实施例的植物面膜粉，包括以下重量份数的植物原料：雪莲花4份，贝母6份，西洋参5份，三七4份，冬虫夏草2份，人参8份，沙棘2份，当归9份，丹参2份，熊果4份，甘草5份。
本实施例的植物面膜粉的制备方法，包括以下步骤：
（1）将上述植物原料清洗干净，55度烘干后按照重量份数混合在一起；
（2）将步骤（1）的混合植物原料研磨成粉末，并将粉末过100目筛，收集过筛后的粉末；
（3）将步骤（2）中过筛后的粉末采用干热灭菌处理，即得所述的植物面膜粉。
实施例3
本实施例的植物面膜粉，包括以下重量份数的植物原料：雪莲花10份，贝母12份，西洋参12份，三七8份，冬虫夏草6份，人参8份，沙棘6份，当归13份，丹参6份，熊果8份，甘草3份。
本实施例的植物面膜粉的制备方法，包括以下步骤：
（1）将上述植物原料清洗干净，53度烘干后按照重量份数混合在一起；
（2）将步骤（1）的混合植物原料研磨成粉末，并将粉末过200目筛，收集过筛后的粉末；
（3）将步骤（2）中过筛后的粉末采用真空紫外灭菌处理，即得所述的植物面膜粉。
Claims (6)
1.一种植物面膜粉，其特征在于：包括以下重量份数的植物原料：雪莲花4～10份，贝母6～12份，西洋参5～12份，三七4～8份，冬虫夏草2～6份，人参3～8份，沙棘2～6份，当归9～13份，丹参2～6份，熊果4～8份，甘草3～5份。
2.根据权要求1所述的植物面膜粉，其特征在于：包括以下重量份数的植物原料：雪莲花6份，贝母8份，西洋参7份，三七5份，冬虫夏草4份，人参6份，沙棘4份，当归10份，丹参4份，熊果5份，甘草4份。
3.如权利要求1或2所述的植物面膜粉的制备方法，其特征在于：包括日如下步骤：
（1）将上述植物原料清洗干净，烘干后按照重量份数混合在一起；
（2）将步骤（1）的混合植物原料研磨成粉末，并将粉末过100～200目筛，收集过筛后的粉末；
（3）将步骤（2）中过筛后的粉末灭菌处理，即得所述的植物面膜粉。
4.根据权利要求3所述的植物面膜粉的制备方法，其特征在于：所述步骤（1）中采用的烘干温度为50～55℃。
5.根据权利要求3所述的植物的制备方法，其特征在于：所述步骤（2）中筛网目数为150。
6.根据权利要求3所述的植物的制备方法，其特征在于：所述步骤（3）中灭菌处理采用真空紫外灭菌或干热灭菌。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810505363.9A CN108379199A (zh) | 2018-05-24 | 2018-05-24 | 一种植物面膜粉 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810505363.9A CN108379199A (zh) | 2018-05-24 | 2018-05-24 | 一种植物面膜粉 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108379199A true CN108379199A (zh) | 2018-08-10 |
Family
ID=63071060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810505363.9A Pending CN108379199A (zh) | 2018-05-24 | 2018-05-24 | 一种植物面膜粉 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108379199A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111956548A (zh) * | 2020-08-24 | 2020-11-20 | 耒阳市刘燕酿制生物科技有限公司 | 一种具有美白作用的精华液制备方法 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103932970A (zh) * | 2014-04-30 | 2014-07-23 | 温州市姿妃韵化妆品有限公司 | 一种中草药祛斑组合化妆品及其制备方法 |
| CN104784100A (zh) * | 2015-04-27 | 2015-07-22 | 武汉庄守和生物科技有限公司 | 一种面膜组合物及其制备方法和应用 |
| CN105456167A (zh) * | 2015-12-23 | 2016-04-06 | 覃腾英 | 一种美白中药面膜 |
| CN106176550A (zh) * | 2016-08-30 | 2016-12-07 | 徐媛媛 | 美白中药面膜及其制备方法 |
| CN107789279A (zh) * | 2017-10-18 | 2018-03-13 | 徐伟善 | 一种美白嫩肌祛斑祛痘中药面膜 |
| CN107811915A (zh) * | 2017-11-17 | 2018-03-20 | 张玉金 | 一种中药面膜、制备方法及其使用方法 |
-
2018
- 2018-05-24 CN CN201810505363.9A patent/CN108379199A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103932970A (zh) * | 2014-04-30 | 2014-07-23 | 温州市姿妃韵化妆品有限公司 | 一种中草药祛斑组合化妆品及其制备方法 |
| CN104784100A (zh) * | 2015-04-27 | 2015-07-22 | 武汉庄守和生物科技有限公司 | 一种面膜组合物及其制备方法和应用 |
| CN105456167A (zh) * | 2015-12-23 | 2016-04-06 | 覃腾英 | 一种美白中药面膜 |
| CN106176550A (zh) * | 2016-08-30 | 2016-12-07 | 徐媛媛 | 美白中药面膜及其制备方法 |
| CN107789279A (zh) * | 2017-10-18 | 2018-03-13 | 徐伟善 | 一种美白嫩肌祛斑祛痘中药面膜 |
| CN107811915A (zh) * | 2017-11-17 | 2018-03-20 | 张玉金 | 一种中药面膜、制备方法及其使用方法 |
Non-Patent Citations (1)
| Title |
|---|
| 李旻辉等: "《沙棘》", 31 July 2016, 中国医药科技出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111956548A (zh) * | 2020-08-24 | 2020-11-20 | 耒阳市刘燕酿制生物科技有限公司 | 一种具有美白作用的精华液制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101485830B (zh) | 一种中药抗衰老保健胶囊 | |
| CN107737041A (zh) | 一种新型皮肤抗敏修护组合物、皮肤修复霜及其制备方法 | |
| KR20120038585A (ko) | 탈모방지용 한방추출물 및 이를 포함하는 헤어용품 조성물 | |
| CN103747779B (zh) | 毛发促生剂及其制作方法 | |
| CN100493548C (zh) | 给肌肤去斑、增白、去皱的美容制剂及其制备方法 | |
| CN103961521A (zh) | 一种用于治疗再生障碍性血液病的中药组合物及制备方法 | |
| CN102836098A (zh) | 中草药组合物美容精华素 | |
| CN101502588B (zh) | 一种美容祛痘组合物及其制备方法 | |
| CN105265672B (zh) | 一种核桃分心木茶的生产方法 | |
| CN110624089A (zh) | 一种可生发育发的外用中药组合物及其制备方法 | |
| CN107744569A (zh) | 一种具有养发、生发功效的精华液及其制备方法 | |
| CN103734767B (zh) | 一种保健食品 | |
| CN106265438A (zh) | 中药杏仁美容面膜 | |
| CN104147147A (zh) | 一种用于治疗皮肤病的中药组合物及制备方法 | |
| CN108379199A (zh) | 一种植物面膜粉 | |
| CN118340846A (zh) | 具有抗慢性咽炎作用的石斛复方制剂、制备方法和应用 | |
| CN105168756B (zh) | 一种含有艾叶提取物的咀嚼片 | |
| CN107961323A (zh) | 一种痤疮药膏及其制备方法 | |
| CN103263582A (zh) | 一种减肥药方 | |
| CN1211095C (zh) | 一种降压护心的片剂 | |
| Algethami et al. | Bee pollen: Clinical trials and patent applications. Nutrients. 2022, 14, 2858 | |
| CN107952036B (zh) | 一种降血糖的中药制剂及其制备方法 | |
| CN112402569A (zh) | 一种抗疲劳保健品及其制备方法 | |
| CN104083621A (zh) | 治疗高血脂的中药制剂 | |
| CN104127686A (zh) | 一种外用药膏组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180810 |
|
| RJ01 | Rejection of invention patent application after publication |